LABS DELBERT
SpecialtyLABS DELBERT is a specialty pharmaceutical company focused on Infectious Disease, Respiratory, Dermatology.
LABS DELBERT's Key Drugs
LABS DELBERT's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
LABS DELBERT's Recent FDA Approvals
New NDA/BLA approvals for LABS DELBERT over the last two years — novel drugs only, excluding generics and label supplements.
LABS DELBERT's Therapeutic Areas
LABS DELBERT's approved drugs and pipeline span 3 therapeutic areas, led by Infectious Disease and Respiratory, across 0 biologic and 1 small-molecule drug. Weighted by commercial stage — approved drugs count most, then late-stage trials.
LABS DELBERT's Top Competitors
LABS DELBERT's closest competitors by therapeutic-area and drug-target overlap include APOTHECON, PHARMACIA AND UPJOHN, and Pfizer. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
LABS DELBERT Pipeline Snapshot
Active clinical trials for LABS DELBERT across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Infectious Disease pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1986-12-31
- Latest
- 2021-04-16
- Applications
- 1